Moderna

CAMBRIDGE, MA · Founded 2013 · CIK 0001592247 · Biotech · Public

mRNA platform that instructs cells to produce therapeutic proteins

modernatx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$556M
2 Form D · Jan 2015
141 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$110,000,026
Private capital raisedForm D · SEC$446,069,409
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1125VERSATOPE THERAPEUTICS, INC.——
1126Inhibrx, Inc.—$669M
1127Odyssey Therapeutics—$571M
1128Moderna—$556M
1129Mariana Oncology——
1130OMVAX, INC.——
1131Denali Therapeutics—$500M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Noubar AfeyanDirector
  • Lee BabissDirector
  • Stephane BancelDirector · Executive Officer
  • Robert CarpenterDirector
  • Peter HuttDirector
  • James KasingerExecutive Officer
  • Lorence KimExecutive Officer
  • Robert LangerDirector
  • Theo Melas-KyriaziDirector
  • John MendleinDirector
  • Henri TermeerDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.